智通财经APP讯,先声药业(02096)发布公告,于2025年3月25日,其议决根据2021年受限制股份单位计划按零代价向合共45名合资格参与者授出合共177.7万份受限制股份单位(相当于177.7万股相关股份),惟须待承授人接纳。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.